Functional Characterization Experiment summary for ENCSR176UAM

doi:10.17989/ENCSR176UAM

Summary

Status
released
Assay
STARR-seq
Biosample summary
Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours
Biosample Type
cell line
Replication type
isogenic
Treatments
1 μM CpdA for 4 hours
Nucleic acid type
RNA
Library starting quantity
75µg
Size range
900-1000
Extraction method
Qiagen RNA extraction
Strand specificity
Strand-specific (reverse)
Controls

Attribution

ENCODE4 project
Lab
Tim Reddy, Duke
Award
UM1HG009428 (Tim Reddy, Duke)
Project
ENCODE
Aliases
tim-reddy:A549-wg-starrseq-CpdA
Date submitted
June 11, 2021
Date released
June 17, 2021

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Modifications
Library
21Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS371JSEENCGM016JFTENCLB955TTJ
23Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS371JSEENCGM016JFTENCLB688YPK
14Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS177LZSENCGM016JFTENCLB512WDB
13Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS177LZSENCGM016JFTENCLB233TPV
12Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS177LZSENCGM016JFTENCLB358LPL
32Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS164IKWENCGM016JFTENCLB911HNP
24Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS371JSEENCGM016JFTENCLB247YNF
31Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS164IKWENCGM016JFTENCLB461YXX
42Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS563VWNENCGM016JFTENCLB158ZIC
43Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS563VWNENCGM016JFTENCLB648KGE
22Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS371JSEENCGM016JFTENCLB374DAX
33Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS164IKWENCGM016JFTENCLB366YHT
44Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS563VWNENCGM016JFTENCLB333FIK
11Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS177LZSENCGM016JFTENCLB069LIM
34Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS164IKWENCGM016JFTENCLB266HWW
41Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hoursENCBS563VWNENCGM016JFTENCLB851UDL